Abstract
A Turkish family with Huntington's disease documented on CT, MRI and SPECT is reported. Whereas in clinically definite cases CT and MRI are of limited value and SPECT does not add anything of value, in one asymptomatic subject SPECT showed moderate caudate nucleus hypoperfusion, underlining the hypothesis that SPECT may have a role in predicting Huntington's disease.
Similar content being viewed by others
References
Bruyn GW (1968) Huntington's chorea: historical, clinical and laboratory synopsis. In: Vinken PJ, Bruyn GW (eds) Handbook of clinical neurology, vol 6. North Holland, Amsterdam, pp 298–378
Bruyn GW, Went LN (1986) Huntington's chorea. In: Vinken PJ, Bruyn GW, Klawans HL (eds) Handbook of clinical neurology, vol 49. Elsevier, Amsterdam, pp 267–313
Gusella JF, Wexler NS, Conneally PM, Naylor SL, Anderson MA, Tanzi RE, Watkins PC, Ottina K, Wallace MR, Sakaguchi AY, Young AB, Shoulson I, Bonilla E, Martin JB (1983) A polymorphic DNA marker genetically linked to Huntington's disease. Nature 306:234–238
Lang C (1985) Is direct CT caudatometry superior to indirect parameters in confirming Huntington's disease? Neuroradiology 27:161–163
Starkstein SE, Folstein SE, Brandt J, Pearlson GD, McDonnell A, Folstein M (1989) Brain atrophy in Huntington's disease. Neuroradiology 31:156–159
Simmons JT, Pastakia B, Chase TN, Shults CW (1986) Magnetic resonance imaging in Huntington's disease. AJNR 7:25–28
Reid IC, Besson JAO, Best PV, Sharp PF, Gemmell HG, Smith FW (1988) Imaging of cerebral blood flow markers in Huntington's disease using single photon emission computed tomography. J Neurol Neurosurg Psychiatry 51:1264–1268
Kido D, Shoulson I, Manzione J, Harnish P (1990) Measurement of caudate nucleus and putamen atrophy in patients with Huntington's disease. 14th Sumposium Neuroradiologicum, 17–23 June 1990. Springer, London, Book of abstracts
Botsch H, Oepen G, Deutschl G, Wolff G (1987) SPECT-Untersuchungen mit99mTc-HMPAO bei Patienten mit Huntingtonscher Chorea. Fortschr Röntgenstr 147:666–668
Smith FW, Gemmell HG, Sharp PF, Besson JAO (1988)99mTc-HMPAO imaging in patients with basal ganglia disease. Br J Radiol 61:914–920
Leblhuber F, Höll K, Reisecker F, Gebetsberger B, Pühringer W, Trenkler J, Deisenhammer E (1989) Single photon emission computed tomography in Huntington's chorea. Psychiatry Res 9: 337–340
Leblhuber F, Brucker B, Reisecker F, Trenkler J (1989) Single photon emission computed tomography (SPECT) in probable Huntington's chorea (HC). J Neural Transm 1:93–94
Leblhuber F, Brucker B, Reisecker F, Steinparz F, Windhager E, Trenkler J, Deisenhammer E (1990) Single photon emission computed tomography in subjects at risk for Huntington's chorea. J Neurol 237:496–498
Kuhl DE, Markham CH, Metter EJ, Reige WH, Winter J (1982) Cerebral metabolism and atrophy in Huntington's disease determined by18FDG and computed tomographic scan. Ann Neurol 12:425–434
Leys D, Pruvo JP, Petit H, Gaudet Y, Clarisse J (1989) Maladie d'Alzheimer. Analyse statistique des résultats du scanner X. Rev Neurol (Paris) 145:134–139
Bayulkem F, Turek I (1961) Huntington's chorea in Turkey. Psychiatr Q 35:258–260
tiner SH, Dührüsken OS (1954) Huntington's chorea (in Turkish). Dirim 8:28
Suchowersky O, Hayden MR, Martin WRW, Stoesll AJ, Hildebrand AH, Pate BD (1986) Cerebral metabolism of glucose in benign hereditary chorea. Mov Disord 1:33–45
Palella TD, Hichwa RD, Ehrenkaufer RL (1985)18F-fluorodeoxyglucose PET scanning in HPRT deficiency. Am J Hum Genet 37:A70
Hosokawa S, Ichiya Y, Kuwabara Y, Ayabe Z, Mitsuo K, Goto I, Kato M (1987) Positron emission tomography in cases of chorea with different underlying diseases. J Neurol Neurosurg Psychiatry 50:1284–1287
Mazziotta JC, Phelps ME, Pahl JJ, Huang S-C, Baxter LR, Riege WH, Hoffman JM, Kuhl DE, Lanto AB, Wapenski JA, Markham CH (1987) Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease. N Engl J Med 316:357–362
Hayden MR, Hewitt J, Stoessl AJ, Clark C, Ammann W, Martin WRW (1987) The combined use of positron emission tomography and DNA polymorphisms for preclinical detection of Huntington's disease. Neurology 37:1441–1447
Young AB, Penney JB, Starosta-Rubinstein S, Markel D, Berent S, Rothley J, Betley A, Hochwa R (1987) Normal caudate glucose metabolism in persons at risk for Huntington's disease. Arch Neurol 44:254–257
Grafton ST, Mazziotta JC, Pahl JJ, Hyslop PStG, Haines JL, Gusella J, Hoffman JM, Baxter LR, Phelps ME (1990) A comparison of neurological, metabolic, structural, and genetic evaluations in persons at risk for Huntington's disease. Ann Neurol 28: 614–621
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bruyn, R.P.M., Hageman, G., Geelen, J.A.G. et al. SPECT, CT and MRI in a Turkish family with huntington's disease. Neuroradiology 35, 525–528 (1993). https://doi.org/10.1007/BF00588713
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF00588713